Cell Line : MDA-MB-175-VII
Cellosaurus Index : CVCL_1400
Cellosaurus ID : MDA-MB-175-VII
CCLE Name
: MDAMB175VII_BREAST
GDSC1 Name
, GDSC2 Name
: MDA-MB-175-VII
CTRP2 Name
: MDAMB175VII
Cancer Type : breast
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| MDA-MB-175-VII | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | 5-azacytidine | GDSC2 | 0.0200 | 20.0000 |
|
| MDA-MB-175-VII | 5-Fluorouracil | GDSC1,GDSC2 | 0.0195 | 32.0000 |
|
| MDA-MB-175-VII | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | A-366 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | A-83-01 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-175-VII | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-175-VII | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | AGI-6780 | GDSC1 | 0.0020 | 0.5120 |
|
| MDA-MB-175-VII | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| MDA-MB-175-VII | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| MDA-MB-175-VII | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| MDA-MB-175-VII | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | Alisertib | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | Alpelisib | GDSC2 | 0.0050 | 10.0000 |
|
| MDA-MB-175-VII | alpha-lipoic acid | GDSC2 | 0.1211 | 121.0000 |
|
| MDA-MB-175-VII | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | Ara-G | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| MDA-MB-175-VII | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| MDA-MB-175-VII | AS605240 | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-175-VII | ascorbate (vitamin C) | GDSC2 | 2.0011 | 2000.0000 |
|
| MDA-MB-175-VII | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | AT13148 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| MDA-MB-175-VII | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MDA-MB-175-VII | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-175-VII | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-175-VII | AZD4547 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| MDA-MB-175-VII | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| MDA-MB-175-VII | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | AZD5582 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-175-VII | AZD6482 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | AZD7762 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| MDA-MB-175-VII | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | AZD8055 | GDSC1,GDSC2 | 0.0010 | 2.0000 |
|
| MDA-MB-175-VII | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| MDA-MB-175-VII | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| MDA-MB-175-VII | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| MDA-MB-175-VII | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| MDA-MB-175-VII | BDP-00009066 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Bexarotene | GDSC1 | 0.0312 | 8.0000 |
|
| MDA-MB-175-VII | BI-2536 | GDSC2 | 0.0010 | 10.0000 |
|
| MDA-MB-175-VII | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Bicalutamide | GDSC1 | 0.0040 | 10.0000 |
|
| MDA-MB-175-VII | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Bleomycin | GDSC1 | 0.2500 | 64.0000 |
|
| MDA-MB-175-VII | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | Bleomycin (50 uM) | GDSC1,GDSC2 | 0.0400 | 50.0000 |
|
| MDA-MB-175-VII | BMS-345541 | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-175-VII | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | BMS-754807 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Bortezomib | GDSC2 | 0.0000 | 0.0200 |
|
| MDA-MB-175-VII | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-175-VII | BPD-00008900 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| MDA-MB-175-VII | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | BX795 | GDSC1 | 0.0195 | 5.0000 |
|
| MDA-MB-175-VII | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Cabozantinib | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| MDA-MB-175-VII | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| MDA-MB-175-VII | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-175-VII | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | CCT-018159 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| MDA-MB-175-VII | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| MDA-MB-175-VII | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| MDA-MB-175-VII | CHIR-99021 | GDSC1 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | Cisplatin | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| MDA-MB-175-VII | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-175-VII | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| MDA-MB-175-VII | CPI-637 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Crizotinib | GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-175-VII | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | CT7033-2 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Cytarabine | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-175-VII | Dabrafenib | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-175-VII | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| MDA-MB-175-VII | Dactolisib | GDSC1,GDSC2 | 0.0003 | 0.2500 |
|
| MDA-MB-175-VII | Daporinad | GDSC1,GDSC2 | 0.0001 | 1.0000 |
|
| MDA-MB-175-VII | Dasatinib | GDSC2 | 0.0010 | 2.0000 |
|
| MDA-MB-175-VII | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| MDA-MB-175-VII | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| MDA-MB-175-VII | Doramapimod | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | Doxorubicin | GDSC1 | 0.0040 | 5.0000 |
|
| MDA-MB-175-VII | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Elesclomol | GDSC1 | 0.0008 | 0.2000 |
|
| MDA-MB-175-VII | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| MDA-MB-175-VII | Entinostat | GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-175-VII | Enzastaurin | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-175-VII | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | Epirubicin | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-175-VII | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| MDA-MB-175-VII | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Erlotinib | GDSC2,CCLE | 0.0020 | 8.0000 |
|
| MDA-MB-175-VII | Etoposide | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-175-VII | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Fedratinib | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-175-VII | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| MDA-MB-175-VII | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-175-VII | FMK | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-175-VII | Foretinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| MDA-MB-175-VII | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-175-VII | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| MDA-MB-175-VII | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-175-VII | Gemcitabine | GDSC1,GDSC2 | 0.0001 | 10.0000 |
|
| MDA-MB-175-VII | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | glutathione | GDSC2 | 0.6403 | 640.0000 |
|
| MDA-MB-175-VII | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| MDA-MB-175-VII | GSK-LSD1-2HCl | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-175-VII | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | GSK1070916 | GDSC1 | 0.0100 | 10.2400 |
|
| MDA-MB-175-VII | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| MDA-MB-175-VII | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | GSK269962A | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | GSK2830371 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | GSK343 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | GSK429286A | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-175-VII | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-175-VII | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-175-VII | HG-5-113-01 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | HG-5-88-01 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | HKMTI-1-005 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | I-BET-762 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | ICL-SIRT078 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Idelalisib | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-175-VII | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | IOX2 | GDSC1 | 0.0004 | 0.1000 |
|
| MDA-MB-175-VII | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| MDA-MB-175-VII | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Irinotecan | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| MDA-MB-175-VII | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| MDA-MB-175-VII | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | KU-55933 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | L-685458 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-175-VII | Lapatinib | GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-175-VII | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-175-VII | LCL161 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| MDA-MB-175-VII | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-175-VII | LGK974 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-175-VII | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-175-VII | Linsitinib | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Luminespib | GDSC1,GDSC2 | 0.0001 | 1.0000 |
|
| MDA-MB-175-VII | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-175-VII | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| MDA-MB-175-VII | MG-132 | GDSC2 | 0.0156 | 4.0000 |
|
| MDA-MB-175-VII | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| MDA-MB-175-VII | MIM1 | GDSC1,GDSC2 | 0.0100 | 40.0000 |
|
| MDA-MB-175-VII | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Mirin | GDSC1 | 0.3906 | 100.0000 |
|
| MDA-MB-175-VII | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-175-VII | MK-1775 | GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | MK-2206 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-175-VII | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MDA-MB-175-VII | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Mycophenolic acid | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | N-acetyl cysteine | GDSC2 | 2.0011 | 2000.0000 |
|
| MDA-MB-175-VII | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | N25720-51-A1 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | N27922-53-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | N29087-69-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | N30652-18-1 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Navitoclax | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-175-VII | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | Nilotinib | GDSC1,GDSC2,CCLE | 0.0020 | 8.0000 |
|
| MDA-MB-175-VII | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-175-VII | NSC319726 | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-175-VII | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| MDA-MB-175-VII | Nutlin-3a | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-175-VII | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | NVP-TAE684 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-175-VII | Obatoclax Mesylate | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| MDA-MB-175-VII | Olaparib | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| MDA-MB-175-VII | OSI-027 | GDSC1,GDSC2 | 0.0039 | 20.0000 |
|
| MDA-MB-175-VII | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-175-VII | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-175-VII | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | PAC-1 | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-175-VII | Paclitaxel | GDSC2,CCLE | 0.0000 | 8.0000 |
|
| MDA-MB-175-VII | Palbociclib | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-175-VII | Panobinostat | GDSC1,CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-175-VII | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-175-VII | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-175-VII | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-175-VII | Pazopanib | GDSC1 | 0.0312 | 8.0000 |
|
| MDA-MB-175-VII | PBD-288 | GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-175-VII | PD0325901 | GDSC1,GDSC2,CCLE | 0.0003 | 8.0000 |
|
| MDA-MB-175-VII | PD173074 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-175-VII | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-175-VII | Pemetrexed | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | Pevonedistat | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| MDA-MB-175-VII | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | PF-4708671 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-175-VII | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | PFI3 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-175-VII | PHA-793887 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| MDA-MB-175-VII | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | Pictilisib | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| MDA-MB-175-VII | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Piperlongumine | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| MDA-MB-175-VII | PLX-4720 | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-175-VII | POMHEX | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| MDA-MB-175-VII | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | QL-VIII-58 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | QL-XII-61 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-175-VII | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | RAF265 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-175-VII | Rapamycin | GDSC2 | 0.0000 | 0.0200 |
|
| MDA-MB-175-VII | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Ribociclib | GDSC2 | 0.0020 | 4.0000 |
|
| MDA-MB-175-VII | RO-3306 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| MDA-MB-175-VII | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-175-VII | Ruxolitinib | GDSC1 | 0.0040 | 5.2400 |
|
| MDA-MB-175-VII | Sapitinib | GDSC2 | 0.0049 | 10.0000 |
|
| MDA-MB-175-VII | Saracatinib | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-175-VII | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-175-VII | SB216763 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | SB505124 | GDSC1 | 0.0391 | 20.0000 |
|
| MDA-MB-175-VII | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-175-VII | SCH772984 | GDSC2 | 0.0049 | 5.0000 |
|
| MDA-MB-175-VII | Selisistat | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Selumetinib | GDSC1,GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-175-VII | Sepantronium bromide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| MDA-MB-175-VII | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-175-VII | SL0101 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | SN-38 | GDSC1,GDSC2 | 0.0000 | 0.1000 |
|
| MDA-MB-175-VII | SNX-2112 | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-175-VII | Sorafenib | GDSC2,CCLE | 0.0025 | 10.0000 |
|
| MDA-MB-175-VII | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| MDA-MB-175-VII | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| MDA-MB-175-VII | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | TAK-715 | GDSC1 | 0.0400 | 20.0000 |
|
| MDA-MB-175-VII | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Tanespimycin | GDSC1,GDSC2,CCLE | 0.0010 | 8.0000 |
|
| MDA-MB-175-VII | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-175-VII | Taselisib | GDSC2 | 0.0050 | 10.0000 |
|
| MDA-MB-175-VII | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Temozolomide | GDSC1,GDSC2 | 0.0293 | 30.0000 |
|
| MDA-MB-175-VII | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| MDA-MB-175-VII | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| MDA-MB-175-VII | THR-101 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | THR-102 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | THR-103 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| MDA-MB-175-VII | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| MDA-MB-175-VII | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| MDA-MB-175-VII | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-175-VII | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | TL-2-105 | GDSC1 | 0.0200 | 10.2400 |
|
| MDA-MB-175-VII | Topotecan | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-175-VII | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Tozasertib | GDSC2 | 0.0049 | 5.0000 |
|
| MDA-MB-175-VII | TPCA-1 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-175-VII | Tretinoin | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| MDA-MB-175-VII | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | TW 37 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| MDA-MB-175-VII | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | Ulixertinib | GDSC2 | 0.0020 | 10.0000 |
|
| MDA-MB-175-VII | UMI-77 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | UNC0379 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | UNC0638 | GDSC1,GDSC2 | 0.0050 | 40.0000 |
|
| MDA-MB-175-VII | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| MDA-MB-175-VII | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| MDA-MB-175-VII | Uprosertib | GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-175-VII | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| MDA-MB-175-VII | Vinblastine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| MDA-MB-175-VII | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| MDA-MB-175-VII | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | Vorinostat | GDSC1,GDSC2 | 0.0049 | 10.0000 |
|
| MDA-MB-175-VII | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | VTP-A | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-175-VII | VTP-B | GDSC2 | 0.0010 | 1.0000 |
|
| MDA-MB-175-VII | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| MDA-MB-175-VII | Wee1 Inhibitor | GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| MDA-MB-175-VII | Wnt-C59 | GDSC1 | 0.0020 | 0.5120 |
|
| MDA-MB-175-VII | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| MDA-MB-175-VII | XAV939 | GDSC1 | 0.0195 | 5.0000 |
|
| MDA-MB-175-VII | XMD11-85h | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| MDA-MB-175-VII | XMD8-92 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | YK-4-279 | GDSC1,GDSC2 | 0.0200 | 20.0000 |
|
| MDA-MB-175-VII | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| MDA-MB-175-VII | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| MDA-MB-175-VII | ZG-10 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| MDA-MB-175-VII | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| MDA-MB-175-VII | ZM447439 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| MDA-MB-175-VII | ZSTK474 | GDSC1 | 0.0200 | 10.2400 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC